XML 19 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Warrant [Member]
Common Stock Subscribed [Member]
Subscription Receivable [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2014 4,232,400              
Balance at Dec. 31, 2014 $ 423,240 $ 11,353,508 $ 25,324     $ 287,082 $ (4,809,086) $ 7,280,068
Balance at Dec. 31, 2015 $ 517,725 17,018,285 15,876 $ 13,799 $ (827,952) (100,477) (6,146,463) $ 10,490,793
Common stock issued upon exercise of warrants, $6.00 per share (in shares) 944,845             944,845
Common stock issued upon exercise of warrants, $6.00 per share $ 94,485 5,584,033 (9,448)         $ 5,669,070
Costs associated with warrant exercise   (733,409)           (733,409)
Common stock subscribed   814,153   13,799 (827,952)      
Other comprehensive loss           (387,559)   (387,559)
Net loss             (1,337,377) (1,337,377)
Balance (in shares) at Dec. 31, 2015 5,177,245              
Balance at Mar. 31, 2016 $ 553,204 18,119,460   900 (54,012) 171,102 (6,473,180) $ 12,317,474
Common stock issued upon exercise of warrants, $6.00 per share (in shares) 354,794             354,794
Common stock issued upon exercise of warrants, $6.00 per share $ 35,479 2,109,161 (15,876)         $ 2,128,764
Costs associated with warrant exercise   (246,945)           (246,945)
Common stock subscribed   (761,041)   (12,899) 773,940      
Other comprehensive loss           271,579   271,579
Net loss             (326,717) (326,717)
Balance (in shares) at Mar. 31, 2016 5,532,039              
Balance (in shares) at Dec. 31, 2015 5,177,245              
Balance at Dec. 31, 2015 $ 517,725 17,018,285 15,876 13,799 (827,952) (100,477) (6,146,463) 10,490,793
Balance at Dec. 31, 2016 $ 556,595 18,017,163       239,461 (7,432,236) 11,380,983
Common stock issued upon exercise of warrants, $6.00 per share (in shares) 372,003              
Common stock issued upon exercise of warrants, $6.00 per share $ 37,200 2,210,694 $ (15,876)         2,232,018
Common stock issued, $7 per share (in shares) 16,695              
Common stock issued, $7 per share $ 1,670 115,195           116,865
Costs associated with common stock issued   (512,858)           (512,858)
Common stock subscribed   (814,153)   $ (13,799) $ 827,952    
Other comprehensive loss           339,938   339,938
Net loss             (1,285,773) (1,285,773)
Balance (in shares) at Dec. 31, 2016 5,565,943              
Balance at Mar. 31, 2017 $ 558,371 18,069,599       262,498 (7,600,984) 11,289,484
Common stock issued, $7 per share (in shares) 17,759              
Common stock issued, $7 per share $ 1,776 122,537           124,313
Costs associated with common stock issued   $ (70,101)           (70,101)
Other comprehensive loss           $ 23,037   23,037
Net loss             $ (168,748) $ (168,748)
Balance (in shares) at Mar. 31, 2017 5,583,702